reference/28225230

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28225230

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	446
issn	1573-7217 0167-6806
issueIdentifier	2
pageRange	441-446
publicationName	Breast Cancer Research and Treatment
startingPage	441
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_49281f5dd9e3c70543f6a41d52169005 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a5b3a6b81be8accfcd6ece8bcf688749 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2698aff67830c1867c836e4fa8179430 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5481bab18e2602da4ce8833909e7d14a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3dfca6bacf8651ce5add859d4f5746d7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1ac80d28e2728eb9c147e187f729f696 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_224374394fb4f90facf6ae8ad5ac4c2a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a75f619009e23d6ad2625d2f9ab21191 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ce645c3f4c5c6739428b1d3f6ccd9883
bibliographicCitation	van Londen GJ, Perera S, Vujevich K, Rastogi P, Lembersky B, Brufsky A, Vogel V, Greenspan SL. The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer. Breast Cancer Research and Treatment. 2010 Nov 03;125(2):441–6. doi: 10.1007/s10549-010-1223-2.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df50d0ebf84c06e407c06a76d8044718 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45594cfd9a8ae9152d96e811e5456738 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73c7ab013256edc635081f67dc623c5e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a80a99cc54321ba08db43e680907989 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_249062ec4bd6a4010be5cbc77d55499b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de2c5dfefbbcaea62bddce1434bf6263 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_104e41c4a5b9aba27f88b318047e5256 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2445a9616db31e7efd2d03e3ca7ffccb
date	2010-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s10549-010-1223-2 https://pubmed.ncbi.nlm.nih.gov/PMC3103776 https://pubmed.ncbi.nlm.nih.gov/21046232
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1254 https://portal.issn.org/resource/ISSN/1573-7217 https://portal.issn.org/resource/ISSN/0167-6806
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer
discusses	http://id.nlm.nih.gov/mesh/M0016932 http://id.nlm.nih.gov/mesh/M000603388 http://id.nlm.nih.gov/mesh/M0019743 http://id.nlm.nih.gov/mesh/M0456327 http://id.nlm.nih.gov/mesh/M0441053 http://id.nlm.nih.gov/mesh/M0020098
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d445780815638f183c8f68566998507 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5245 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676225 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f02b83a26fc01f93e52937e4314d7c5 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128649586 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127711966 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128171553 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129506098

Total number of triples: 59.